Oxford University, which showed promise on Monday in the first phase of tests, two more Covid-19 vaccines showed promising results in their early-stage trials today.CanSino Biologics Inc.’s experimental coronavirus vaccine showed potential results in a mid-stage clinical study, paving the way for the next phase of tests as it jostles with Western pharma giants to deliver one of the first pandemic vaccines.The shot was shown to be safe and induced an immune response, according to a study released in the medical journal The Lancet.
Still, the authors stressed that no participants were exposed to SARS-CoV-2 virus after vaccination, so it wasn’t possible for this study to determine whether the candidate effectively protects against.